Alternative donor SCT for the treatment of MHC Class II deficiency

Bone Marrow Transplantation

Volumn 48, Issue 2, 2013, Pages 226-232

  Small, T N ^a   Qasim, W ^b   Friedrich, W ^c   Chiesa, R ^b   Bleesing, J J ^d   Scurlock, A ^e   Veys, P ^b   Sparber Sauer, M ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

immunodeficiency; MHC Class II deficiency; transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HAEMOPHILUS INFLUENZAE VACCINE; HLA ANTIGEN; IMMUNOGLOBULIN; INFLUENZA VACCINE; MELPHALAN; MYCOPHENOLIC ACID; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; TACROLIMUS; TETANUS TOXOID; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; AGE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; BARE LYMPHOCYTE SYNDROME; BLOOD DONOR; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; INFANT; INFLUENZA; MALE; PNEUMONIA; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; UNRELATED DONORS; UPPER RESPIRATORY TRACT INFECTION;

CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; MALE; TISSUE DONORS;

EID: 84873455892     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.140     Document Type: Article

References (20)

1. Elhasid R, Etzioni A. Major histocompatibility complex class II deficiency: A clinical review. Blood Rev 1996; 10: 242-248
2. Reith W, Mach B. The Bare lymphocyte syndrome and the regulation of MHC Expression. Annu Rev Immunol 2001; 19: 331-373
3. Villard J, Masternak K, Lisowska-Grospierre B, Fischer A, Reith W. MHC class II deficiency: A disease of gene regulation. Medicine 2001; 80: 405-418
4. Saleem MA, Arkwright PD, Davies EG, Cant AJ, Veys PA. Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child 2000; 83: 356-359
5. Klein C, Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli CJ. Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome. J Pediatr 1993; 123: 921-928
6. Klein C, Cavazzana-Calvo M, Frangoise Le Deist F, Jabado N, Benkerrou M, Blanche S et al. Bone marrow transplantation in major histocompatibility complex class II deficiency: A single-center study of 19 patients. Blood 1995; 85: 580-587
7. Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: A survey of 35 patients. Blood 2011; 118: 5108-5118
8. Al-Ghonaium A. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Bone Marrow Transplant 2008; 42: S53-S56
9. Al-Mousa H, Al-Shammari Z, Al Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B et al. Allogeneic stem cell transplantation using myeloablative and reducedintensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transplant 2010; 16: 818-823
10. Renella R, Picard C, Neven B, Ouachee-Chardin M, Casanova J-L, Le Deist F et al. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatibility complex class II immunodeficiency: Reduced survival correlates with an increased incidence of acute graft-versus-host disease and preexisting viral infections. Br J Haematol 2006; 134: 510-516
11. Bonduel M, Del Pozo A, Zelazko M, Raslaswki E, Delfino S, Rossi J et al. Successful related umbilical cord blood transplantation for graft failure following T celldepleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant 1999; 24: 437-440
12. Bonduel M, Staciuk R, Figueroa C, Oleastro M, Gamba C, Rossi J et al. Unrelated cord blood transplantation and reduced-intensity conditioning regimen for graft failure in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant 2009; 43: 817-818
13. Chiesa R, Gilmour K, Qasim W, Adams S, Worth AJ, Zhan H et al. Omission of in vivo T-cell depletion promotes rapid expansion of nai?ve CD4 cord blood lymphocytes and restores adaptive immunity within two months after unrelated cord blood transplant. Br J Haematol 2012; 156: 656-666
14. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304
15. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276
16. Shearer WT, Rosenblatt HM, Gelman S, Oyomopito R, Plaeger S, Stiehm ER et al. Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973-980
17. Small TN, Friedrich W, O'Reilly RJ. Hematopoietic cell transplantation for immunodeficiency diseases. In: Forman S, Blume KG, Thomas ED (eds) Hematopoietic Cell Transplantation. 4th edn vol. 75, Blackwell Science: Malden, MA, 2009; pp 1105-1124
18. Grusby MJ, Glimcher LH. Immune responses in MHC class II-deficient mice. Ann Rev Immunol 1995; 13: 417-435
19. Munchel A, Kesserwan C, Symons HJ, Luznik L, Kasamon YL, Jones RJ et al. HLAhaploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. Pediatr Rep 2011; 3(Suppl 2): E15
20. Li W, Kim M-G, Gourley TS, McCarthy BP, Sant'Angelo DB, Chang CH. An alternate pathway for CD4 T cell development: Thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 2005; 23: 375-386